The EPO published EP3596095A1, a patent application by Inbiose N.V. for crystallizing 2'-fucosyllactose (2'-FL), a human milk oligosaccharide used in infant nutrition and dietary supplements. The application claims methods and compositions under IPC classifications C07H 1/00, C07H 3/06, A61K 31/702, A23L 33/00, and A23L 33/125. The patent is designated for all EU member states plus associated countries (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR).

Patent publications do not impose compliance obligations. Competitors in the infant nutrition, pharmaceutical, or dietary supplement sectors should review the patent claims for freedom-to-operate assessments and potential licensing considerations. The original document can be viewed at the EPO Register using application number EP3596095.